For 20 years, advocates of telemedicine have been trying to break through to common usage. For all of modern human history, those with mental health challenges have held back from seeking treatment due to the stigma associated with doing so. And then, a Chinese bat opened the flood gates. Today we are seeing record usage of telemedicine, especially for mental health needs of all types.
Regular Tech Tonics listeners know our usual approach is in-depth personal interviews with individuals. Today, in light of current events, we decided to take a topical detour into how the coronavirus pandemic has driven vast advances in the use of telemedicine and has brought out into the open the importance of access to mental health treatment. The combination of these things into what we know now as tele-behavioral health, is our topic today. We invited three tele-behavioral health experts serving different populations to join the show and share with us what they are seeing in the new world order; those people are:
- Steve Smith, CEO of NOCD
- Russell Glass, CEO of Ginger
- Margaret Laws, co-founder of Nod (and CEO of HopeLab)
Notably, all three of these organizations are experiencing skyrocketing use of their tele-behavioral health products and have seen some surprising customers enter their system. Interestingly, the pandemic has driven a stunning rise in telemedicine, but also a much greater openness to discussing and acting on the need for mental health care. Un-hampered by lack of reimbursement or physician/provider reluctance, these companies’ digital approaches are gaining in popularity in a way that may be persistent post-crisis. And not only are patients enjoying their experiences; they consistently report that access challenges have been markedly reduced as compared to the pre-pandemic era. Imagine that.
Never has the need for mental health care been more acute. The Kaiser Family Foundation notes that “More than four in ten adults overall (45%) feel that worry and stress related to coronavirus has had a negative impact on their mental health, up from 32% in early March.” If one needed more proof of the mental health crisis we are facing, prescriptions per week for antidepressants, anti-anxiety and anti-insomnia drugs increased by 21% between February 16 and March 15, peaking the week of March 15 when the virus was deemed a pandemic. The largest increase was in anti-anxiety medications, according to the report, which rose by 34.1% over that month, in contrast to double digit drops in the use of some of these medications over the previous five years, according to this Fierce Healthcare article.
We are grateful to our guests for their willingness to do the show and even more so for their commitment tackling the issues that are plaguing so many people today. Whether you are an adult, a child, a teen; whether you are someone with serious mental health issues or more common ones; whether you are alone, with your family, or in any other situation, know that there is help out there for you – you can access mental health services 24-hours a day by telemedicine by accessing these three companies and many others.
To listen to the show, please use the audio player below or find it on the Connected Social Media website or on iTunes.
Show Notes:
Kaiser Family Foundation report on coronavirus impact on mental health
Great Forbes article about Nod and how it can help during the pandemic
Press Release about Free Access to Mental Health Coaching during the Pandemic
Article about NOCD and how it’s addressing rising need to treat OCD during the crisis
Lisa’s article on the dramatic rise in digital health as a result of the pandemic.
David’s interview in Timmerman Report with his brother, Jonathan, a psychiatrist in L.A. who was an early adopter of telemedicine. Jonathan discusses his first-hand experiences adjusting to this technology.
Cynthia Joyce says
Hi Lisa – really important discussion. You recruited from among the best in the mental health business & so glad you are highlighting them at a time when we might prevent problems generated by Covid.
The challenge for consumers is how to choose from the more than 10,000 mental health apps out there – and not just on price. There is a risk of harm. Just to share with you…the APA has worked on an evaluation framework (privacy, evidence-base, ownership etc..) and a team at BIDMC in Boston has started the process of app eval . Wanted to share a link to the site with you…its early days and a bit wonky – but probably the most serious attempt to provide objective evidence in the field. Would be great to see players like your guests help bring order to the marketplace……..
https://apps.digitalpsych.org/
Lisa Suennen says
Thanks Cynthia – great to see the resource. I agree, there is chaos and patients deserve to know high quality vs. not so much. Best, Lisa
Rick Lee says
If we miss the opportunity of measurement based care (leading to value based payments) during this access surge, shame on us. A simple screen pre and post that quantifies the degree of distress (anxiety, depression, OCD, PTSD, Sub Abuse, etc) needs to be standardized in the industry. Then we can separate the wheat from the chaff in terms of provider quality. Licensing doesn’t cut it. Measuring improvement does.
Great panel. Very thought provoking
Lisa Suennen says
So true Rick – hopefully this is finally the opportunity to improve outcomes – lord knows there’s plenty of demand. Lisa
M says
testing to see if you moderate